498 related articles for article (PubMed ID: 28595941)
1. Epidemiology of mucopolysaccharidoses.
Khan SA; Peracha H; Ballhausen D; Wiesbauer A; Rohrbach M; Gautschi M; Mason RW; Giugliani R; Suzuki Y; Orii KE; Orii T; Tomatsu S
Mol Genet Metab; 2017 Jul; 121(3):227-240. PubMed ID: 28595941
[TBL] [Abstract][Full Text] [Related]
2. Estimated birth prevalence of mucopolysaccharidoses in Brazil.
Federhen A; Pasqualim G; de Freitas TF; Gonzalez EA; Trapp F; Matte U; Giugliani R
Am J Med Genet A; 2020 Mar; 182(3):469-483. PubMed ID: 31926052
[TBL] [Abstract][Full Text] [Related]
3. Prevalence rates of mucopolysaccharidoses in Poland.
Jurecka A; Ługowska A; Golda A; Czartoryska B; Tylki-Szymańska A
J Appl Genet; 2015 May; 56(2):205-10. PubMed ID: 25472774
[TBL] [Abstract][Full Text] [Related]
4. Incidence of the mucopolysaccharidoses in Northern Ireland.
Nelson J
Hum Genet; 1997 Dec; 101(3):355-8. PubMed ID: 9439667
[TBL] [Abstract][Full Text] [Related]
5. The live-birth prevalence of mucopolysaccharidoses in Estonia.
Krabbi K; Joost K; Zordania R; Talvik I; Rein R; Huijmans JG; Verheijen FV; Õunap K
Genet Test Mol Biomarkers; 2012 Aug; 16(8):846-9. PubMed ID: 22480138
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities.
Puckett Y; Mallorga-Hernández A; Montaño AM
Orphanet J Rare Dis; 2021 May; 16(1):241. PubMed ID: 34051828
[TBL] [Abstract][Full Text] [Related]
7. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004.
Lin HY; Lin SP; Chuang CK; Niu DM; Chen MR; Tsai FJ; Chao MC; Chiu PC; Lin SJ; Tsai LP; Hwu WL; Lin JL
Am J Med Genet A; 2009 May; 149A(5):960-4. PubMed ID: 19396827
[TBL] [Abstract][Full Text] [Related]
8. Cumulative incidence rates of the mucopolysaccharidoses in Germany.
Baehner F; Schmiedeskamp C; Krummenauer F; Miebach E; Bajbouj M; Whybra C; Kohlschütter A; Kampmann C; Beck M
J Inherit Metab Dis; 2005; 28(6):1011-7. PubMed ID: 16435194
[TBL] [Abstract][Full Text] [Related]
9. [Estimation of the mucopolysaccharidoses frequencies and cluster analysis in the Colombian provinces of Cundinamarca and Boyacá].
Gómez AM; García-Robles R; Suárez-Obando F
Biomedica; 2012; 32(4):602-9. PubMed ID: 23715235
[TBL] [Abstract][Full Text] [Related]
10. Incidence of mucopolysaccharidoses in Tunisia.
Ben Turkia H; Tebib N; Azzouz H; Abdelmoula MS; Ben Chehida A; Chemli J; Monastiri K; Chaabouni M; Sanhagi H; Zouari B; Kaabachi N; Ben Dridi MF
Tunis Med; 2009 Nov; 87(11):782-5. PubMed ID: 20209839
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of obstructive sleep apnea in patients with mucopolysaccharidosis types I, II, and VI in a reference center.
Moreira GA; Kyosen SO; Patti CL; Martins AM; Tufik S
Sleep Breath; 2014 Dec; 18(4):791-7. PubMed ID: 24705807
[TBL] [Abstract][Full Text] [Related]
13. Incidence of the mucopolysaccharidoses in Western Australia.
Nelson J; Crowhurst J; Carey B; Greed L
Am J Med Genet A; 2003 Dec; 123A(3):310-3. PubMed ID: 14608657
[TBL] [Abstract][Full Text] [Related]
14. Comparison of growth dynamics in different types of MPS: an attempt to explain the causes.
Różdżyńska-Świątkowska A; Zielińska A; Tylki-Szymańska A
Orphanet J Rare Dis; 2022 Sep; 17(1):339. PubMed ID: 36064607
[TBL] [Abstract][Full Text] [Related]
15. [Mucopolysaccharidoses. New therapeutic possibilities increase the need of early diagnosis].
Malm G; Bondeson ML; von Döbeln U; Månsson JE
Lakartidningen; 2002 Apr; 99(16):1804-9. PubMed ID: 12043480
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
[TBL] [Abstract][Full Text] [Related]
17. Rapid identification of San Filippo disease (MPS III).
Kelly S; Schedlbauer L; Leikhim E
Health Lab Sci; 1978 Jul; 15(3):123-7. PubMed ID: 151669
[TBL] [Abstract][Full Text] [Related]
18. Cardiac manifestations of the mucopolysaccharidoses.
Schieken RM; Kerber RE; Ionasescu VV; Zellweger H
Circulation; 1975 Oct; 52(4):700-5. PubMed ID: 808361
[TBL] [Abstract][Full Text] [Related]
19. Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses.
Oguni T; Tomatsu S; Tanaka M; Orii K; Fukao T; Watanabe J; Fukuda S; Notsu Y; Vu DC; Can TBN; Nagai A; Yamaguchi S; Taketani T; Gelb MH; Kobayashi H
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188102
[TBL] [Abstract][Full Text] [Related]
20. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
